Vancouver, British Columbia, December 15, 2022 /PRNewswire/ — EmeTerm, an anti-nausea wristband developed by WAT Medical Enterprise, Ltd., received FDA approval in 2018 as a medical device to treat nausea-induced vomiting. In December 2022, EmeTerm enters the retail market with the launch of a new product, EmeTerm Explore, at Walmart and Best Buy Canada.
Since the COVID-19 pandemic, outdoor activities have become more common than ever, and driving travel is returning around the world. However, almost one in five (18%) suffered from motion sickness. More than a third (37%) of drivers report that they often take breaks because passengers feel unwell in the car, and many choose to forego their trips or even avoid them altogether.
EmeTerm uses neuromodulation, a clinically proven technology that alters electrical signals in the body. The current is delivered through the P6 point on the lower wrist. The advantage of neuromodulation in anti-nausea and vomiting is its fast onset of action and zero drug-induced side effects.
EmeTerm Explore is equipped with natural medical silicone rubber to reduce carbon footprint and prevent allergic reactions. The new design features enhanced device-to-skin conduction of electrical impulses without the need for a conduction gel. This makes the device more affordable and convenient for everyday activities.
Walmart and Best Buy are the biggest leaders in consumer electronics. This marks the beginning of EmeTerm’s debut and entry into the global market.
View the original content and download the multimedia: https://www.prnewswire.com/news-releases/emeter-enters-walmart-and-best-buy-with-new-technology-301703559.html
Source WAT Medical Enterprise Co., Ltd.